Press release
Rare Gastrointestinal Diseases Treatment Market to Reach USD 1.68 Billion by 2031 Fueled by Advancements in Genomic Medicine and Drug Development
Rare Gastrointestinal Diseases Treatment Market
According to the latest research by InsightAce Analytic, the Global Rare Gastrointestinal Diseases Treatment Market is valued at US$ 1.29 Bn in 2022, and it is expected to reach US$ 1.68 Bn by 2031, with a CAGR of 3.1% during a forecast period of 2023-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2075
Rare gastrointestinal (GI) diseases encompass a diverse group of uncommon conditions affecting the digestive tract. The rarity and limited clinical understanding of these disorders often present challenges in both diagnosis and treatment.
The global market for rare gastrointestinal disease therapies includes a wide range of conditions, such as rare forms of inflammatory bowel disease (IBD), gastrointestinal motility disorders, genetic syndromes that impair digestion and nutrient absorption, rare GI cancers, and autoimmune-related digestive disorders. Market growth is being driven by the rising incidence of these rare diseases, alongside the development and approval of targeted therapeutic drugs.
Government initiatives and increased funding for the treatment of digestive disorders are further accelerating market expansion. Additional contributing factors include advancements in diagnostic technologies, enhanced healthcare infrastructure, and greater availability of effective treatments offering prompt symptom relief. Furthermore, ongoing research and development activities, coupled with the discovery of novel therapeutic agents, continue to support the growth of this sector.
The increasing prevalence of rare diseases among the aging population is also contributing to market demand. In particular, the biopharmaceutical industry is focusing on the development of biologic therapies aimed at managing these complex conditions, reinforcing the market's upward trajectory.
List of Prominent Players in the Rare Gastrointestinal Diseases Treatment Market:
• Bayer Pharmaceutical Corp
• Teva Pharmaceutical
• Novartis AG
• Sanofi
• Pfizer, Inc.
• GlaxoSmithKline PLC
• Eli Lilly and CO.
• Johnson & Johnson
• Others
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics
Drivers:
The expansion of biotechnology firms specializing in rare diseases has brought innovation and specialized expertise to the market. These companies often pursue a targeted approach to drug development, aiming to address unmet medical needs within niche segments. Scientific advancements-particularly in genetic research and precision therapeutics-are creating new opportunities for the development of breakthrough treatments for rare gastrointestinal disorders. Moreover, progress in genomics, personalized medicine, and advanced drug delivery technologies is enhancing the ability to diagnose and treat these complex conditions more accurately and effectively.
Challenges:
The treatment landscape for rare gastrointestinal diseases is confronted with several significant challenges, primarily due to the low prevalence and complex pathophysiology of these conditions. Limited therapeutic options and a smaller patient population reduce commercial incentives, often resulting in reduced research funding compared to more common diseases. This financial constraint hampers the ability to fully understand disease mechanisms and develop effective therapies.
Regional Trends:
North America is anticipated to hold a leading share of the rare gastrointestinal diseases treatment market, with strong revenue performance and a projected high compound annual growth rate (CAGR). This growth is driven by lifestyle-related factors contributing to a rising incidence of gastrointestinal conditions, as well as proactive government initiatives focused on prevention and treatment. In the Asia-Pacific (APAC) region, growing interest in genomic research is creating opportunities to explore the region's genetic diversity. This can support the development of personalized therapies tailored to rare gastrointestinal diseases within diverse population groups.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2075
Recent Developments:
• In May 2022, Eli Lilly and Company started the CONFIDE Study to learn more about the prevalence of inflammatory bowel illnesses and how they impact patients. The organization created the CONFIDE portal to better understand how gastrointestinal illnesses impact patients' physical and mental health. The business also intends to provide patients with individualized therapy.
• In May 2020, Teva Pharmaceutical Industries Ltd. made an announcement regarding the approval of AUSTEDO® (Deutetrabenazine Tablets) by the China National Medical Products Administration (NMPA). This approval, which followed a priority review, pertains to the use of AUSTEDO® in the treatment of chorea associated with Huntington's disease (HD) and Tardive Dyskinesia (TD) in adults. China has become the second nation, following the United States, to provide approval for the usage of AUSTEDO.
Segmentation of Rare Gastrointestinal Diseases Treatment Market-
By Treatment-
• Medications
• Nutritional support
By End-User-
• Hospitals
• Research Institutes
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/rare-gastrointestinal-diseases-treatment-market/2075
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rare Gastrointestinal Diseases Treatment Market to Reach USD 1.68 Billion by 2031 Fueled by Advancements in Genomic Medicine and Drug Development here
News-ID: 4017370 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Biologics CDMO Market Exclusive Report with Detailed Study Analysis
"Biologics CDMO Market" in terms of revenue was estimated to be worth $24.02 billion in 2024 and is poised to reach $ 125.5 billion by 2034, growing at a CAGR of 18.1% from 2025 to 2034 according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2233
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Biologics CDMO market are:
• Growing demand for biologics and…
Conversational Commerce Market Exclusive Report on the Latest Revenue and Future …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Conversational Commerce Market Size, Share & Trends Analysis Report By Component (Solution, Services), Type (Chatbots And Intelligent Virtual Assistants), Deployment Mode (Cloud And On-Premises), Enterprises Size (Small And Mid-Sized Enterprises (Smes) And Large Enterprises), Business Function (Sales, Finance, HR, Operation, And IT Service Management.) And Industry (BFSI, Healthcare And Life Sciences, IT & Telecom,…
AI in Personalized Learning and Education Technology Market Report Latest Trends …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI in Personalized Learning and Education Technology Market - (By Type (Machine Learning Algorithms, Natural Language Processing (NLP) Systems, Expert Systems, Computer Vision Applications, Intelligent Tutoring Systems (ITS), Virtual Learning Environments (VLEs), Adaptive Learning Platforms), By Application (Adaptive Content Delivery, Personalized Learning Paths, Individualized Assessment and Feedback, Intelligent Content Creation, Smart Content Recommendations, Personalized Learning…
Exosome Research Market Current Scenario with Future Aspect Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exosome Research Market Size, Share & Trends Analysis Report By Products & Services (Kits And Reagents, Instruments And Services), Disease Indications (Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, And Infectious Diseases), Applications (Biomarkers, Vaccine Development, Tissue Regeneration ) And End Users (Academic & Research Institutes, Pharmaceutical And Biotechnology Companies, Hospitals & Clinical Testing Laboratories)- Market Outlook And…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
